Clinically Significant Drug Interactions with Antacids

@article{Ogawa2012ClinicallySD,
  title={Clinically Significant Drug Interactions with Antacids},
  author={Ryuichi Ogawa and Hirotoshi Echizen},
  journal={Drugs},
  year={2012},
  volume={71},
  pages={1839-1864}
}
One may consider that drug-drug interactions (DDIs) associated with antacids is an obsolete topic because they are prescribed less frequently by medical professionals due to the advent of drugs that more effectively suppress gastric acidity (i.e. histamine H2-receptor antagonists [H2RAs] and proton pump inhibitors [PPIs]). Nevertheless, the use of antacids by ambulant patients may be ever increasing, because they are freely available as over-the-counter (OTC) drugs. Antacids consisting of weak… 
PHARMACOKINETIC INTERACTION BETWEEN ANTACID AND COMMONLY PRESCRIBED MEDICATIONS-METFORMIN, DICLOFENAC, AMOXICILLIN
TLDR
Antacids influence pharmacokinetics of Amoxicillin, Diclofenac and Metformin by reducing their bioavailability, and this study observed variation in all pharmacokinetic parameters.
Acid suppression therapy and allergic reactions
TLDR
These drugs should only be prescribed based on a precise gastroenterological diagnosis taking into consideration allergological mechanisms to ensure patients’ safety, and disruption of the gastrointestinal barrier function, changes in microbiome, or lack of tolerogenic peptic digests might contribute to the connection between anti-ulcer drug intake and allergic reaction.
Acid suppression therapy and allergic reactions
TLDR
These drugs should only be prescribed based on a precise gastroenterological diagnosis taking into consideration allergological mechanisms to ensure patients’ safety, and disruption of the gastrointestinal barrier function, changes in microbiome, or lack of tolerogenic peptic digests might contribute to the connection between anti-ulcer drug intake and allergic reaction.
A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions with Orally Administered Medications
TLDR
This systematic review of gastric pH-mediated DDIs may provide a resource to healthcare professionals in aiding the care of patients by increasing awareness of interactions with ARAs and may also identify and potentially aid in avoiding clinically relevant DDIs and preventing risk of treatment failure and/or adverse effects.
Mebeverine HCl and Aluminium/Magnesium Antacid Interactions: A Potential Impact on Electrolyte Replacement Therapy
TLDR
Calorimetry and infrared results suggest that mebeverine HCl interacts with the antacids and with Movicol, and it is advisable to administer other drugs at least 0.5-1.0 h before antacid ingestion to ensure consistent absorption and effect and to avoid potential interactions.
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers
TLDR
Neither famotidine nor antacid significantly affected nilotinib pharmacokinetics, and different dosing separation schemes leading to a minimized drug–drug interaction was explored.
Pharmacokinetic drug-drug interaction and their implication in clinical management
  • C. Palleria, A. Di Paolo, L. Gallelli
  • Medicine, Biology
    Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
  • 2013
TLDR
In this review, using Medline, PubMed, Embase, Cochrane library and Reference lists, articles published until June 30 2012 are searched, and the mechanism of pharmacokinetic DDIs are described focusing the interest on their clinical implications.
Introduction to Drug-Drug Interactions
TLDR
This chapter provides a broad overview of clinical pharmacology from the perspective of systems that influence absorption, distribution, metabolism, and excretion of drugs that can lead to pharmacokinetic drug interactions.
Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion
TLDR
This chapter describes the mechanisms of drug interactions for each of the aforementioned pharmacokinetic processes, including the cytochrome P450 family of enzymes, the P-glycoprotein drug transporter, and their mechanisms for inhibition, induction, and suppression.
Incidence of Potential Drug–Drug Interactions in Cardiac Patients in a Tertiary Care Hospital
  • P. Sudha
  • Medicine, Political Science
  • 2018
TLDR
The overall incidence of pDDIs was found to be more in males compared to females, it was found that incidence was associated with old age, polypharmacy and increased lengths of hospital stay, and the majority of interactions were pharmacodynamic in nature, having major severity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 190 REFERENCES
Lack of Effect of Antacids on Single‐Dose Pharmacokinetics of Etoricoxib
TLDR
The results of a 4-period, 2part, open-label study designed to assess the intrasubject variability of etoricoxib pharmacokinetics in healthy subjects treated concomitantly with antacids containing salts of calcium, magnesium, and aluminum are reported.
Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
  • R. Polk
  • Biology, Medicine
    The American journal of medicine
  • 1989
Effects of the Antacids in Didanosine Tablets on Dapsone Pharmacokinetics
TLDR
Two studies were conducted to determine whether the currently available didanosine tablet decreases the absorption of dapsone and whether the magnesium-aluminum antacids or other excipients in the tablet can produce a decreased absorption.
Drug-Drug Interaction Profiles of Proton Pump Inhibitors
TLDR
It has been suggested that coadministration of PPIs with a dual antiplatelet therapy consisting of clopidogrel and aspirin may attenuate the anti-aggregation effects of those medications and augment the risk of cardiovascular ischaemic events.
Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.
TLDR
The safe and effective use of fluoroquinolone antibiotics requires careful consideration of concomitant drug therapy, and the metabolism of theophylline and caffeine is inhibited by enoxacin and ciprofloxacIn, and reduction of the theophyLLine dosage is not routinely required.
Lack of Pharmacokinetic Interaction between Linezolid and Antacid in Healthy Volunteers
TLDR
The results of this study demonstrate that the oral absorption of linezolid was not affected by the presence of antacids containing magnesium hydroxide and aluminum Hydroxide, and can be safely administered together with linezolic.
Pharmacokinetic interaction between flurbiprofen and antacids in healthy volunteers.
TLDR
The results indicate that the co-administration of Maalox with flurbiprofen had no effect on the rate and extent of total flurbIProfen absorption in young volunteers and in geriatric volunteers, and no effect of the antacid on the extent of drug absorption.
Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
TLDR
Rabeprazole was well tolerated at the 20 mg dose level when given with or without antacid, and the pharmacokinetic parameters, Cmax, t(max), AUC and t1/2, showed no statistically significant differences when rabeprazoles was administered alone, concomitantly with antacid or one hour after antacid administration.
Effect of antacid on imatinib absorption
TLDR
The results indicate that the use of Mg2+-Al3+-based antacid does not significantly affect imatinib absorption, and indeed, antacid co-administration with dasatinib does result in a twofold decrease in dasasinib absorption.
Interaction of warfarin and nonsystemic gastrointestinal drugs
TLDR
In vitro experiments demonstrated significant binding of warfarin to cholestyramine at a pH above its pKa of 5.5, and neither the antacid nor psyllium colloid was found to alter plasma concentrations or pharmacologic action of warFarin.
...
1
2
3
4
5
...